Crescent Biopharma CBIO
NASDAQ CBIO
$16.23 -1.09 (-6.29%)
At close: Aug 20, 2026 · 4:00 PM EDT

Crescent Biopharma (CBIO) EBIT Margin Growth (3y) (2016)

Crescent Biopharma (CBIO) EBIT Margin Growth (3y) (2016) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn -377.00
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn -204.00
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -537.00
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -1,934.00
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 7,261.00
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 9,003.00
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 30,461.00
8 Royalty Pharma 26.98 Bn 26.14 Bn - -2,649.00
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -11,254.00
10 Crescent Biopharma 1.05 Bn 875.92 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2016 -3.56 Mn